165 related articles for article (PubMed ID: 10849891)
1. Donepezil, a centrally acting acetylcholinesterase inhibitor, alleviates learning deficits in hypocholinergic models in rats.
Ogura H; Kosasa T; Kuriya Y; Yamanishi Y
Methods Find Exp Clin Pharmacol; 2000 Mar; 22(2):89-95. PubMed ID: 10849891
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological properties of donepezil hydrochloride (Aricept), a drug for Alzheimer's disease].
Ogura H; Kosasa T; Araki S; Yamanishi Y
Nihon Yakurigaku Zasshi; 2000 Jan; 115(1):45-51. PubMed ID: 10876815
[TBL] [Abstract][Full Text] [Related]
3. Combination of a novel antidementia drug FK960 with donepezil synergistically improves memory deficits in rats.
Tokita K; Yamazaki S; Yamazaki M; Matsuoka N; Mutoh S
Pharmacol Biochem Behav; 2002 Oct; 73(3):511-9. PubMed ID: 12151024
[TBL] [Abstract][Full Text] [Related]
4. Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine.
Wang T; Tang XC
Eur J Pharmacol; 1998 May; 349(2-3):137-42. PubMed ID: 9671090
[TBL] [Abstract][Full Text] [Related]
5. Effects of novel tacrine-related cholinesterase inhibitors in the reversal of 3-quinuclidinyl benzilate-induced cognitive deficit in rats--Is there a potential for Alzheimer's disease treatment?
Misik J; Korabecny J; Nepovimova E; Kracmarova A; Kassa J
Neurosci Lett; 2016 Jan; 612():261-268. PubMed ID: 26708634
[TBL] [Abstract][Full Text] [Related]
6. Huperzine A, a novel promising acetylcholinesterase inhibitor.
Cheng DH; Ren H; Tang XC
Neuroreport; 1996 Dec; 8(1):97-101. PubMed ID: 9051760
[TBL] [Abstract][Full Text] [Related]
7. Ameliorative effects of azaindolizinone derivative ZSET845 on scopolamine-induced deficits in passive avoidance and radial-arm maze learning in the rat.
Yamaguchi Y; Higashi M; Matsuno T; Kawashima S
Jpn J Pharmacol; 2001 Nov; 87(3):240-4. PubMed ID: 11885975
[TBL] [Abstract][Full Text] [Related]
8. Reversal of visual attention dysfunction after AMPA lesions of the nucleus basalis magnocellularis (NBM) by the cholinesterase inhibitor donepezil and by a 5-HT1A receptor antagonist WAY 100635.
Balducci C; Nurra M; Pietropoli A; Samanin R; Carli M
Psychopharmacology (Berl); 2003 Apr; 167(1):28-36. PubMed ID: 12618916
[TBL] [Abstract][Full Text] [Related]
9. Reversal of scopolamine-induced spatial memory deficits in rats by TAK-147.
Chen Z; Xu AJ; Li R; Wei EQ
Acta Pharmacol Sin; 2002 Apr; 23(4):355-60. PubMed ID: 11931694
[TBL] [Abstract][Full Text] [Related]
10. Two novel 5-HT6 receptor antagonists ameliorate scopolamine-induced memory deficits in the object recognition and object location tasks in Wistar rats.
de Bruin NM; Prickaerts J; van Loevezijn A; Venhorst J; de Groote L; Houba P; Reneerkens O; Akkerman S; Kruse CG
Neurobiol Learn Mem; 2011 Sep; 96(2):392-402. PubMed ID: 21757018
[TBL] [Abstract][Full Text] [Related]
11. Choline pivaloyl esters improve in rats cognitive and memory performances impaired by scopolamine treatment or lesions of the nucleus basalis of Meynert.
Rispoli V; Rotiroti D; Carelli V; Liberatore F; Scipione L; Marra R; Giorgioni G; Di Stefano A
Neurosci Lett; 2004 Feb; 356(3):199-202. PubMed ID: 15036629
[TBL] [Abstract][Full Text] [Related]
12. Long-lasting antiamnesic effect of a novel anticholinesterase inhibitor (MF268).
Braida D; Paladini E; Griffini P; Lamperti M; Colibretti L; Sala M
Pharmacol Biochem Behav; 1998 Apr; 59(4):897-901. PubMed ID: 9586846
[TBL] [Abstract][Full Text] [Related]
13. Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice.
Saxena G; Singh SP; Agrawal R; Nath C
Eur J Pharmacol; 2008 Mar; 581(3):283-9. PubMed ID: 18234183
[TBL] [Abstract][Full Text] [Related]
14. An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors.
Braida D; Paladini E; Griffini P; Lamperti M; Maggi A; Sala M
Eur J Pharmacol; 1996 Apr; 302(1-3):13-20. PubMed ID: 8790986
[TBL] [Abstract][Full Text] [Related]
15. The role of nicotinic receptors in the amelioration of cholinesterase inhibitors in scopolamine-induced memory deficits.
Masuoka T; Kamei C
Psychopharmacology (Berl); 2009 Oct; 206(2):259-65. PubMed ID: 19639304
[TBL] [Abstract][Full Text] [Related]
16. Central and peripheral activity of cholinesterase inhibitors as revealed by yawning and fasciculation in rats.
Ogura H; Kosasa T; Kuriya Y; Yamanishi Y
Eur J Pharmacol; 2001 Mar; 415(2-3):157-64. PubMed ID: 11274994
[TBL] [Abstract][Full Text] [Related]
17. Scopolamine disrupts place navigation in rats and humans: a translational validation of the Hidden Goal Task in the Morris water maze and a real maze for humans.
Laczó J; Markova H; Lobellova V; Gazova I; Parizkova M; Cerman J; Nekovarova T; Vales K; Klovrzova S; Harrison J; Windisch M; Vlcek K; Svoboda J; Hort J; Stuchlik A
Psychopharmacology (Berl); 2017 Feb; 234(4):535-547. PubMed ID: 27885411
[TBL] [Abstract][Full Text] [Related]
18. Antiamnesic and neuroprotective effects of donepezil against learning impairments induced in mice by exposure to carbon monoxide gas.
Meunier J; Ieni J; Maurice T
J Pharmacol Exp Ther; 2006 Jun; 317(3):1307-19. PubMed ID: 16551835
[TBL] [Abstract][Full Text] [Related]
19. Pretraining or previous non-spatial experience improves spatial learning in the Morris water maze of nucleus basalis lesioned rats.
Nieto-Escámez FA; Sánchez-Santed F; de Bruin JP
Behav Brain Res; 2004 Jan; 148(1-2):55-71. PubMed ID: 14684248
[TBL] [Abstract][Full Text] [Related]
20. Lancemaside A isolated from Codonopsis lanceolata and its metabolite echinocystic acid ameliorate scopolamine-induced memory and learning deficits in mice.
Jung IH; Jang SE; Joh EH; Chung J; Han MJ; Kim DH
Phytomedicine; 2012 Dec; 20(1):84-8. PubMed ID: 23079229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
